Transplant & Restorative Surgery Care

A healthy kidney is surgically removed from a matched living donor and transplanted into a recipient with end-stage kidney disease, taking over the filtering role of the failed kidneys.

Indicated for chronic kidney failure requiring dialysis or approaching that stage, where transplantation offers better long-term survival and quality of life than remaining on dialysis.

Under general anaesthesia, the donor kidney is removed laparoscopically and implanted into the recipient's pelvis, with its blood vessels and ureter connected to the recipient's own system under a specialised transplant team; surgery generally takes 3-5 hours.

Most recipients see kidney function normalise within days to weeks, with long-term graft survival supported by lifelong immunosuppression and regular monitoring.

A portion of a healthy donor's liver is surgically removed and transplanted into a recipient with end-stage liver disease; both the donor and recipient segments regenerate to near-full size over following months.

Indicated for cirrhosis, liver failure, certain liver cancers and select metabolic conditions where the liver can no longer sustain the body's needs and no other treatment offers comparable survival benefit.

Under general anaesthesia, surgeons remove the diseased liver and connect the donor graft's blood vessels and bile duct to the recipient's system; the operation typically takes 6-10 hours and requires a specialised hepatobiliary and transplant team.

Most recipients see liver function normalise over days to weeks as the graft regenerates, with one-year survival rates commonly reported above 90% at experienced centres.

All or part of the cornea — the clear front surface of the eye — is removed and replaced with matched donor corneal tissue, using full-thickness (penetrating) or layer-specific (lamellar/endothelial) techniques.

Considered for keratoconus, corneal scarring, infection damage, or endothelial failure where vision or comfort can no longer be restored with glasses, contact lenses or medication.

Under local or general anaesthesia, the surgeon removes the affected corneal tissue and sutures or positions the donor graft in place; the procedure typically takes 45-90 minutes, and donor tissue availability can affect scheduling.

Most patients experience gradual improvement in vision and comfort over weeks to months as the graft integrates, with graft survival rates commonly above 90% at one year for standard indications.

Individual hair follicles are extracted from a donor area (typically the back of the scalp) and implanted into thinning or bald areas, using Follicular Unit Extraction (FUE) or Direct Hair Implantation (DHI) technique.

Considered for male or female pattern hair loss, receding hairlines, or scarring alopecia where the patient wants a permanent, natural-looking restoration rather than ongoing medical management alone.

Under local anaesthesia, the surgeon extracts individual follicular grafts with a fine punch tool and implants them one by one into the recipient area at a natural angle and density; a full session typically takes 4-8 hours depending on graft count.

Transplanted follicles shed initially, then regrow gradually, with visible density improvement from around 4-6 months and final results typically apparent at 12-18 months.

Healthy blood-forming stem cells — from the patient (autologous) or a matched donor (allogeneic) — are infused into the bloodstream to rebuild bone marrow function after it has been ablated by chemotherapy and/or radiation.

Indicated for leukaemia, lymphoma, multiple myeloma, thalassemia, aplastic anaemia and certain other blood, immune or genetic disorders where restoring healthy marrow offers the best chance of long-term remission or cure.

The patient first undergoes conditioning chemotherapy and/or radiation to prepare the marrow space, then receives stem cells intravenously; the infusion itself is brief, but the surrounding treatment cycle, isolation and immune recovery period spans several weeks under specialist haematology care.

Successful engraftment is typically confirmed within 2-4 weeks as blood counts recover, with long-term outcomes depending heavily on underlying disease, donor match quality and the patient's response to conditioning.